Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 13;192(41):E1242-E1246.
doi: 10.1503/cmaj.200528-f.

Considérations pour la prise en charge sécuritaire d’une infection au SRAS-CoV-2 au moyen de chloroquine, d’hydroxychloroquine et d’azithromycine

[Article in French]
David N Juurlink  1
Affiliations
Review

Considérations pour la prise en charge sécuritaire d’une infection au SRAS-CoV-2 au moyen de chloroquine, d’hydroxychloroquine et d’azithromycine

[Article in French]
David N Juurlink. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Intérêts concurrents : Aucun déclaré.

References

    1. Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005;2:69. - PMC - PubMed
    1. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30: 269–71. - PMC - PubMed
    1. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020. le 9 mars [Cyberpublication avant impression] pii ciaa237. 10.1093/cid/ciaa237. - DOI - PMC - PubMed
    1. Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14:72–3. - PubMed
    1. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020. le 20 mars [Cyberpublication avant impression]. 105949. 10.1016/j.ijantimicag.2020.105949. - DOI - PMC - PubMed